Pharmacokinetics and Antihypertensive Effects of Low Dose Clonidine During Chronic Therapy

Abstract

Using a sensitive and specific radioimmunoassay the pharmacokinetic disposition of clonidine was determined in hypertensive patients after a single dose and then after 5, 28 and 56 days of chronic dosing with 75 μg bd. Following a single dose of clonidine maximal plasma concentrations of 0.34 ± 0.06 ng/ml were achieved after 3.6 ± 1.2 hours. After 5 days of repetitive dosing the maximal concentration was significantly higher, 0.66 ± 0.06 ng/ml and remained so throughout chronic therapy (P = 0.018). The AUC, T_max and T_1/2 did not differ significantly between the acute dose and the chronic dosing pharmacokinetic studies. Clonidine also produced a significant fall in blood pressure. Supine diastolic blood pressure fell from 106 ± 5 mmHg predose to 99 ± 6 mmHg 2 hours after the first dose (P < 0.05). The corresponding values after cyclopenthiazide alone were 108 ± 8 and 105 ± 8 mmHg (P = 0.13). Similar falls in blood pressure were produced during chronic therapy.